Compare MSFT & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSFT | BSX |
|---|---|---|
| Founded | 1975 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6T | 137.8B |
| IPO Year | 2008 | 2010 |
| Metric | MSFT | BSX |
|---|---|---|
| Price | $394.64 | $68.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 34 | 20 |
| Target Price | ★ $603.27 | $108.75 |
| AVG Volume (30 Days) | ★ 22.7M | 11.3M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | 15.59 | ★ 55.20 |
| EPS | ★ 8.87 | 1.94 |
| Revenue | ★ $62,484,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $18.77 | $12.04 |
| Revenue Next Year | $15.57 | $10.48 |
| P/E Ratio | $45.32 | ★ $35.33 |
| Revenue Growth | 6.93 | ★ 12.49 |
| 52 Week Low | $355.67 | $67.56 |
| 52 Week High | $555.45 | $109.50 |
| Indicator | MSFT | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 38.78 | 30.45 |
| Support Level | $392.46 | N/A |
| Resistance Level | $413.05 | $76.77 |
| Average True Range (ATR) | 7.69 | 1.87 |
| MACD | 2.17 | 0.06 |
| Stochastic Oscillator | 42.44 | 17.55 |
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.